Newsbenzinga
Relmada Therapeutics Joins Russell 2000 Index And Russell 3000 Index
· Published
Article summary
Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company"))), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today
An excerpt from the original article.
Comments —
Loading comments…